Skip to content

Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device

Safety and Acceptability Study of Non-Surgical Male Circumcision Device for Adult Male Population When Removing the Foreskin Shortly After Placement of Device Performed at Lusaka and Livingstone, Zambia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03132285
Enrollment
500
Registered
2017-04-27
Start date
2017-03-11
Completion date
2017-06-17
Last updated
2017-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Prevention

Brief summary

To assess the safety and acceptability of the non-surgical PrePex device among healthy adult male participants scheduled for voluntary medical male circumcision when removing the foreskin shortly after device placement.

Detailed description

To assess the safety and acceptability of the non-surgical PrePex device among healthy adult male participants scheduled for voluntary medical male circumcision when removing the foreskin shortly after device placement. Five hundred (500) males scheduled for voluntary circumcision performed by clinicians or nurses using the PrePex. Theses clinicians and nurses have already been trained in the Prepex procedure and will undergo further training in the modification to the technique. Study duration per participant will be up to 8 weeks and will include three follow up visits and one phone call follow up.

Interventions

DEVICEPrePex

Prepex is a non surgical male circumcision device

Sponsors

Ministry of Health, Zambia
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
13 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages - 13 to 49 years * Uncircumcised * Participant wants to be circumcised * Participant assent to the procedure * Legal guardian consent to the procedure for ages 13-18 years * Able to understand the study procedures and requirements * Agrees to abstain from sexual intercourse for 8 weeks after circumcision * Agrees to abstain from masturbation for at least 2 weeks after Removal * Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 7 weeks post removal (8 weeks total) * Participant able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study

Exclusion criteria

* Legal guardian withholds consent for ages 13-18 years * Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the participant from undergoing a circumcision * Participant with the following diseases/conditions: phimosis, paraphimosis, adhesions, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias * Known bleeding / coagulation abnormality, uncontrolled diabetes * Participant that to the opinion of the investigator is not a good candidate * Diabetes Mellitus * HIV Sero-positive

Design outcomes

Primary

MeasureTime frameDescription
Number of incidents related to the change in procedure8 weeksTo assess the safety of PrePex device when removing the foreskin shortly after device placement by means of the following parameter: Incidence of Serious Adverse Events, when performed by clinicians and nurses
Acceptability of the changes procedure to patients8 weeksTo asses the new procedure acceptability for patients using the following measures - Evaluation of pain during foreskin removal * Patients willingness to wait for foreskin removal * Odour while device is in situ * Pain at key time points on Removal visit * Discomfort of any type to patients.

Secondary

MeasureTime frameDescription
Effect of the change in procedure on circumcision healing time8 weeksTo assess the circumcision healing time period.

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026